169 related articles for article (PubMed ID: 35947016)
41. Analysis of Extracellular Vesicles in Gastric Juice from Gastric Cancer Patients.
Kagota S; Taniguchi K; Lee SW; Ito Y; Kuranaga Y; Hashiguchi Y; Inomata Y; Imai Y; Tanaka R; Tashiro K; Kawai M; Akao Y; Uchiyama K
Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30813244
[TBL] [Abstract][Full Text] [Related]
42. Synuclein-γ in uterine serous carcinoma impacts survival: An NRG Oncology/Gynecologic Oncology Group study.
Winder AD; Maniar KP; Wei JJ; Liu D; Scholtens DM; Lurain JR; Schink JC; Buttin BM; Filiaci VL; Lankes HA; Ramirez NC; Park K; Singh M; Lieberman RW; Mannel RS; Powell MA; Backes FJ; Mathews CA; Pearl ML; Secord AA; Peace DJ; Mutch DG; Creasman WT; Kim JJ
Cancer; 2017 Apr; 123(7):1144-1155. PubMed ID: 27926776
[TBL] [Abstract][Full Text] [Related]
43. Synuclein-gamma (SNCG) may be a novel prognostic biomarker in uterine papillary serous carcinoma.
Morgan J; Hoekstra AV; Chapman-Davis E; Hardt JL; Kim JJ; Buttin BM
Gynecol Oncol; 2009 Aug; 114(2):293-8. PubMed ID: 19476987
[TBL] [Abstract][Full Text] [Related]
44. Circulating microRNA-203 predicts metastases, early recurrence, and poor prognosis in human gastric cancer.
Imaoka H; Toiyama Y; Okigami M; Yasuda H; Saigusa S; Ohi M; Tanaka K; Inoue Y; Mohri Y; Kusunoki M
Gastric Cancer; 2016 Jul; 19(3):744-53. PubMed ID: 26233325
[TBL] [Abstract][Full Text] [Related]
45. Synuclein-gamma predicts poor clinical outcome in esophageal cancer patients.
Tastekin D; Kargin S; Karabulut M; Yaldız N; Tambas M; Gurdal N; Tatli AM; Arslan D; Gok AF; Aykan F
Tumour Biol; 2014 Dec; 35(12):11871-7. PubMed ID: 25142230
[TBL] [Abstract][Full Text] [Related]
46. Synuclein-γ (SNCG) protein expression is associated with poor outcome in endometrial adenocarcinoma.
Mhawech-Fauceglia P; Wang D; Syriac S; Godoy H; Dupont N; Liu S; Odunsi K
Gynecol Oncol; 2012 Jan; 124(1):148-52. PubMed ID: 22015044
[TBL] [Abstract][Full Text] [Related]
47. Detection of digestive malignancies and post-gastrectomy complications via gastrointestinal fluid examination.
Huang L; Xu A
Front Med; 2017 Mar; 11(1):20-31. PubMed ID: 28213880
[TBL] [Abstract][Full Text] [Related]
48. Gamma-synuclein is a novel prognostic marker that promotes tumor cell migration in biliary tract carcinoma.
Takemura Y; Ojima H; Oshima G; Shinoda M; Hasegawa Y; Kitago M; Yagi H; Abe Y; Hori S; Fujii-Nishimura Y; Kubota N; Masuda Y; Hibi T; Sakamoto M; Kitagawa Y
Cancer Med; 2021 Aug; 10(16):5599-5613. PubMed ID: 34245137
[TBL] [Abstract][Full Text] [Related]
49. A simple biomarker scoring matrix for early gastric cancer detection.
Wu W; Yong WW; Chung MC
Proteomics; 2016 Nov; 16(22):2921-2930. PubMed ID: 27488579
[TBL] [Abstract][Full Text] [Related]
50. Significance of elevated levels of collagen type IV and hyaluronic acid in gastric juice and serum in gastric cancer and precancerous lesion.
Ruan HL; Hong RT; Xie HJ; Hu NZ; Xu JM; Zhang W
Dig Dis Sci; 2011 Jul; 56(7):2001-8. PubMed ID: 21264511
[TBL] [Abstract][Full Text] [Related]
51. Mutagens, N-nitroso compounds and their precursors in gastric juice from patients with and without precancerous lesions of the stomach.
Pignatelli B; Malaveille C; Rogatko A; Hautefeuille A; Thuillier P; Muñoz N; Moulinier B; Berger F; De Montclos H; Lambert R
Eur J Cancer; 1993; 29A(14):2031-9. PubMed ID: 8280498
[TBL] [Abstract][Full Text] [Related]
52. Synuclein-γ (SNCG) expression in ovarian cancer is associated with high-risk clinicopathologic disease.
Strohl A; Mori K; Akers S; Bshara W; Buttin B; Frederick PJ; Helenowski IB; Morrison CD; Odunsi K; Schink JC; Scholtens DM; Wei JJ; Kim JJ
J Ovarian Res; 2016 Nov; 9(1):75. PubMed ID: 27809878
[TBL] [Abstract][Full Text] [Related]
53. Combined phenotype of 4 markers improves prognostic value of patients with colon cancer.
Liu C; Qu L; Dong B; Xing X; Ren T; Zeng Y; Jiang B; Meng L; Wu J; Shou C
Am J Med Sci; 2012 Apr; 343(4):295-302. PubMed ID: 22261620
[TBL] [Abstract][Full Text] [Related]
54. Alternative splicing of synuclein gamma in endometrial cancer: identification of a novel isoform.
Schaal K; Hirschfeld M; Bronsert P; Füllgraf H; Jäger M; Herde B; Nöthling C; Mayer S; Erbes T; Stickeler E
Oncotarget; 2015 Sep; 6(26):22553-63. PubMed ID: 26265438
[TBL] [Abstract][Full Text] [Related]
55. Using gastric juice lncRNA-ABHD11-AS1 as a novel type of biomarker in the screening of gastric cancer.
Yang Y; Shao Y; Zhu M; Li Q; Yang F; Lu X; Xu C; Xiao B; Sun Y; Guo J
Tumour Biol; 2016 Jan; 37(1):1183-8. PubMed ID: 26280398
[TBL] [Abstract][Full Text] [Related]
56. Long noncoding RNA HOXA11-AS promotes gastric cancer cell proliferation and invasion
Liu Y; Zhang YM; Ma FB; Pan SR; Liu BZ
World J Gastroenterol; 2019 Jun; 25(22):2763-2775. PubMed ID: 31235999
[TBL] [Abstract][Full Text] [Related]
57. [Clinical value of serum CEA, CA19-9, CA72-4 and CA242 in the diagnosis and prognosis of gastric cancer].
Zhu YB; Ge SH; Zhang LH; Wang XH; Xing XF; DU H; Hu Y; Li YA; Jia YN; Lin Y; Fan B; Ji JF
Zhonghua Wei Chang Wai Ke Za Zhi; 2012 Feb; 15(2):161-4. PubMed ID: 22368025
[TBL] [Abstract][Full Text] [Related]
58. Applicative Value of Serum CA19-9, CEA, CA125 and CA242 in Diagnosis and Prognosis for Patients with Pancreatic Cancer Treated by Concurrent Chemoradiotherapy.
Gu YL; Lan C; Pei H; Yang SN; Liu YF; Xiao LL
Asian Pac J Cancer Prev; 2015; 16(15):6569-73. PubMed ID: 26434876
[TBL] [Abstract][Full Text] [Related]
59. Noninvasive Detection of Esophageal Cancer by the Combination of mSEPT9 and SNCG.
Zhang L; Yang X; Tian Y; Yu Q; Zhou D; Wu Z; Zhao X
Genet Test Mol Biomarkers; 2022 Jan; 26(1):8-16. PubMed ID: 35089073
[No Abstract] [Full Text] [Related]
60. Serum ENA78/CXCL5, SDF-1/CXCL12, and their combinations as potential biomarkers for prediction of the presence and distant metastasis of primary gastric cancer.
Lim JB; Chung HW
Cytokine; 2015 May; 73(1):16-22. PubMed ID: 25689618
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
